Literature DB >> 20149510

Osteonecrosis of the jaw in a patient on Denosumab.

Tara L Aghaloo1, Alan L Felsenfeld, Sotirios Tetradis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20149510      PMCID： PMC2880179          DOI： 10.1016/j.joms.2009.10.010

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN： 0278-2391            Impact factor:   1.895


× No keyword cloud information.
  61 in total

1.  Protein geranylgeranylation is required for osteoclast formation, function, and survival: inhibition by bisphosphonates and GGTI-298.

Authors:  F P Coxon; M H Helfrich; R Van't Hof; S Sebti; S H Ralston; A Hamilton; M J Rogers
Journal:  J Bone Miner Res       Date:  2000-08       Impact factor: 6.741

2.  Oral ulceration with bone sequestration.

Authors:  C S Farah; N W Savage
Journal:  Aust Dent J       Date:  2003-03       Impact factor: 2.291

Review 3.  Osteoclast differentiation and activation.

Authors:  William J Boyle; W Scott Simonet; David L Lacey
Journal:  Nature       Date:  2003-05-15       Impact factor: 49.962

4.  Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management.

Authors:  Salvatore L Ruggiero; John Fantasia; Eric Carlson
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2006-07-31

5.  Mandibular osteomyelitis and tooth exfoliation following zoster-CMV co-infection.

Authors:  Shabnum Meer; Hedley Coleman; Mario Altini; Terence Alexander
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2005-10-05

6.  A preliminary pilot study of treatment of thrombophilia and hypofibrinolysis and amelioration of the pain of osteonecrosis of the jaws.

Authors:  C J Glueck; R E McMahon; J E Bouquot; T Tracy; L Sieve-Smith; P Wang
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  1998-01

Review 7.  Clinical applications of RANK-ligand inhibition.

Authors:  E Romas
Journal:  Intern Med J       Date:  2009-02       Impact factor: 2.048

8.  Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial.

Authors:  Jacques P Brown; Richard L Prince; Chad Deal; Robert R Recker; Douglas P Kiel; Luiz H de Gregorio; Peyman Hadji; Lorenz C Hofbauer; Jose M Alvaro-Gracia; Huei Wang; Matthew Austin; Rachel B Wagman; Richard Newmark; Cesar Libanati; Javier San Martin; Henry G Bone
Journal:  J Bone Miner Res       Date:  2009-01       Impact factor: 6.741

9.  Bisphosphonates reduce local recurrence in extremity giant cell tumor of bone: a case-control study.

Authors:  Lung Fung Tse; Kwok Chuen Wong; Shekhar Madhukar Kumta; Lin Huang; Tsun Cheung Chow; James Francis Griffith
Journal:  Bone       Date:  2007-09-06       Impact factor: 4.398

10.  Osteonecrosis related to intraosseous anesthesia: report of a case.

Authors:  Karl F Woodmansey; Robert K White; Jianing He
Journal:  J Endod       Date:  2008-12-12       Impact factor: 4.171
View more
  73 in total

Review 1.  The effects of bisphosphonates on jaw bone remodeling, tissue properties, and extraction healing.

Authors:  Matthew R Allen
Journal:  Odontology       Date:  2011-01-27       Impact factor: 2.634

Review 2.  Emerging therapeutic opportunities for skeletal restoration.

Authors:  Masanobu Kawai; Ulrike I Mödder; Sundeep Khosla; Clifford J Rosen
Journal:  Nat Rev Drug Discov       Date:  2011-02       Impact factor: 84.694

3.  Photodynamic Therapy as an adjunct in the Treatment of Medication-Related Osteonecrosis of the Jaw: A Case Report.

Authors:  Marcelo Vieira da Costa Almeida; Antonio C Moura; Lúcia Santos; Luciana Gominho; Ully Dias Nascimento Távora Cavalcanti; Kaline Romeiro
Journal:  J Lasers Med Sci       Date:  2021-03-08

Review 4.  The role of bisphosphonates in multiple myeloma: mechanisms, side effects, and the future.

Authors:  Samantha Pozzi; Noopur Raje
Journal:  Oncologist       Date:  2011-04-14

5.  Bisphosphonate-associated osteonecrosis of the mandible: reliable soft tissue reconstruction using a local myofascial flap.

Authors:  Juliana Lemound; Andrè Eckardt; Horst Kokemüller; Constantin von See; Pit Jacob Voss; Frank Tavassol; Martin Rücker; Majeed Rana; Nils-Claudius Gellrich
Journal:  Clin Oral Investig       Date:  2011-08-05       Impact factor: 3.573

6.  Ovariectomy stimulates and bisphosphonates inhibit intracortical remodeling in the mouse mandible.

Authors:  D J Kubek; D B Burr; M R Allen
Journal:  Orthod Craniofac Res       Date:  2010-11       Impact factor: 1.826

Review 7.  Bisphosphonate-related osteonecrosis of the jaw in non-malignant bone disease.

Authors:  Peter K Wong; Gelsomina L Borromeo; John D Wark
Journal:  Rheumatol Int       Date:  2013-05-08       Impact factor: 2.631

8.  Spontaneous osteonecrosis of the jaws in the maxilla of mice on antiresorptive treatment: a novel ONJ mouse model.

Authors:  Rafael Scaf de Molon; Simon Cheong; Olga Bezouglaia; Sarah M Dry; Flavia Pirih; Joni Augusto Cirelli; Tara L Aghaloo; Sotirios Tetradis
Journal:  Bone       Date:  2014-08-02       Impact factor: 4.398

9.  Osteonecrosis of the Jaw in the Absence of Antiresorptive or Antiangiogenic Exposure: A Series of 6 Cases.

Authors:  Tara L Aghaloo; Sotirios Tetradis
Journal:  J Oral Maxillofac Surg       Date:  2016-07-30       Impact factor: 1.895

10.  Does regular zoledronic acid change the bone turnover of the jaw in men with metastatic prostate cancer: a possible clue to the pathogenesis of bisphosphonate related osteonecrosis of the jaw?

Authors:  Oliver Ristow; Carlos Gerngroß; Markus Schwaiger; Bettina Hohlweg-Majert; Melanie Ristow; Steffen Koerdt; Roswitha Schuster; Sven Otto; Christoph Pautke
Journal:  J Cancer Res Clin Oncol       Date:  2014-01-28       Impact factor: 4.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.